Recruiting A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma NCT06942442 Conditions Clear Cell Sarcoma (CCS), HLA-A*0201 Positive Cells Present, Neoplasms, +5 more Locations University of Southern California - Norris Cancer Center — Los Angeles, California, United States Memorial Sloan Kettering Cancer Center — New York, United States View Trial Details
Recruiting Vebreltinib for Advanced or Metastatic CCS NCT07153887 Conditions Clear Cell Sarcoma (CCS), Neoplasms, Neoplasms by Histologic Type, +4 more Locations The Second Affiliated Hospital Zhejiang University School of Medicine — Hangzhou, Zhejiang, China View Trial Details
Completed Phase 2 Study in Patients With MiT Tumors NCT00557609 Conditions Adenocarcinoma, Alveolar Soft Part Sarcoma (ASPS), Carcinoma, +22 more Locations San Francisco, California, United States Santa Monica, California, United States Miami, Florida, United States Boston, Massachusetts, United States View more locations Show fewer locations Loading locations... View Trial Details
